MERIDIA works by affecting appetite control centers
in the brain. In medical
studies with significantly overweight people [BMI 27 with comorbidities,
BMI 30 with no other disease present],
MERIDIA, along with a reduced-calorie diet, produced
significant reductions in body weight.
 |
The FDA has recently approved
a new class of non-systematically acting anti-obesity medications
known as lipase inhibitors. XENICAL® acts locally in the gastrointestinal tract
to prevent the absorption of some 30 percent of dietary fats.
The best advantage XENICAL® has over other diet aids is that it does not
alter your metabolism or interfere with neurotransmitters in
the brain. It simply blocks fat from being absorbed into the
body.
 |
|
Remember—your
healthcare professional can help you determine the daily calorie
intake that is right for you.
As with any medication, there
are risks. Please educate yourself before deciding to place an
order. |
